Insider Activity Update: Glenn S Boehnlein Executes Options Exercise, Resulting In $71K At Stryker

In a new SEC filing on January 2, it was revealed that Boehnlein, VP at Stryker SYK, executed a significant exercise of company stock options.

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Thursday revealed that Boehnlein, VP at Stryker in the Health Care sector, exercised stock options for 300 shares of SYK stock. The exercise price of the options was $122.51 per share.

During Friday's morning session, Stryker shares up by 0.66%, currently priced at $361.08. Considering the current price, Boehnlein's 300 shares have a total value of $71,571.

All You Need to Know About Stryker

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Financial Insights: Stryker

Revenue Growth: Stryker displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 11.92%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

Insights into Profitability:

• Gross Margin: The company sets a benchmark with a high gross margin of 64.02%, reflecting superior cost management and profitability compared to its peers.

• Earnings per Share (EPS): Stryker's EPS is a standout, portraying a positive bottom-line trend that exceeds the industry average with a current EPS of 2.18.

Debt Management: Stryker's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.77, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Valuation Metrics: A Closer Look

• Price to Earnings (P/E) Ratio: Stryker's P/E ratio of 38.45 is below the industry average, suggesting the stock may be undervalued.

• Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 6.28 suggests overvaluation in the eyes of investors, considering sales performance.

• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 27.23, Stryker presents an attractive value opportunity.

Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Understanding the Significance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.

From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.

A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.

While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.

A Deep Dive into Insider Transaction Codes

In the domain of transactions, investors frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Stryker's Insider Trades.

Insider Buying Alert: Profit from C-Suite Moves

Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.

This article was generated by Benzinga's automated content engine and reviewed by an editor.